| NAUT Stock | | | USD 2.24 0.06 2.61% |
Nautilus Biotechnology financial indicator trend analysis is infinitely more than just investigating Nautilus Biotechnology recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nautilus Biotechnology is a good investment. Please check the relationship between Nautilus Biotechnology Other Operating Expenses and its Ebitda accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nautilus Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in employment.
For more information on how to buy Nautilus Stock please use our
How to Invest in Nautilus Biotechnology guide.
Other Operating Expenses vs Ebitda
Other Operating Expenses vs Ebitda Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Nautilus Biotechnology Other Operating Expenses account and
Ebitda. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Nautilus Biotechnology's Other Operating Expenses and Ebitda is 0.86. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Ebitda in the same time period over historical financial statements of Nautilus Biotechnology, assuming nothing else is changed. The correlation between historical values of Nautilus Biotechnology's Other Operating Expenses and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Nautilus Biotechnology are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Other Operating Expenses i.e., Nautilus Biotechnology's Other Operating Expenses and Ebitda go up and down completely randomly.
Correlation Coefficient | 0.86 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Nautilus Biotechnology. It is also known as Nautilus Biotechnology overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Ebitda
Most indicators from Nautilus Biotechnology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nautilus Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nautilus Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in employment.
For more information on how to buy Nautilus Stock please use our
How to Invest in Nautilus Biotechnology guide.
Selling General Administrative is likely to drop to about 25.5
M in 2024.
Enterprise Value Over EBITDA is likely to drop to -5.49 in 2024
Nautilus Biotechnology fundamental ratios Correlations
Click cells to compare fundamentals
Nautilus Biotechnology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nautilus Biotechnology fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Nautilus Stock Analysis
When running Nautilus Biotechnology's price analysis, check to
measure Nautilus Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nautilus Biotechnology is operating at the current time. Most of Nautilus Biotechnology's value examination focuses on studying past and present price action to
predict the probability of Nautilus Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nautilus Biotechnology's price. Additionally, you may evaluate how the addition of Nautilus Biotechnology to your portfolios can decrease your overall portfolio volatility.